NewsFDA: Animal Testing No Longer Mandatory before Human TrialsSwathi Kodaikal, MScNew FDA law is a “radical shift” in the field of pharmaceutical research and drug development
TechnologyOrgan-on-a-Chip: A Personalized Approach to In Vitro ModelingJake Moskowitz, DVM, PhDIntegrated cell culture and microfluidics provide platforms for research, drug testing, and personalized medicine
InsightNovel Psychoactive Substances: Testing Challenges and StrategiesPallavi Upadhyay, PhDTo keep up with emerging NPS, toxicology labs must develop robust assays and update existing testing panels and menus
InsightMobile Drug Testing: Driving the Future of Compliance Drug MonitoringPallavi Upadhyay, PhDMobile testing frameworks could help deliver better health care to underserved communities
Q&AInnovations in Clinical Trial DesignErica Tennenhouse, PhDMatthew M. Laughon, MD, MPH is a professor at the University of North Carolina (UNC) at Chapel Hill in thedepartment of pediatrics.
FeaturesHow to Detect Tampered Drug TestsRaeesa Gupte, PhDAs drug test adulteration becomes more sophisticated, so do detection methods
InfographicsHow Long Do Drugs Stay in the Body?Today's Clinical LabDuration depends on the biological matrix